key: cord-1051646-ivjdncdn authors: Davies, Kristen title: Resuscitation discussions: learning from Covid‐19 date: 2020-10-09 journal: Clin Teach DOI: 10.1111/tct.13278 sha: f2ac327efae046d97439bfb10adc04d0e0070d2b doc_id: 1051646 cord_uid: ivjdncdn nan I have usually been the first doctor to interact with and assess patients before either admitting them to a ward or discharging them home. Many of these patients have had symptoms of Covid-19 on arrival, many have been unwell, and many have been frail with multiple co-morbidities. The current pandemic has increased the urgency of making sure that these patients have appropriate treatments and, importantly, discussions about escalation of treatment. Treatment escalation refers to the planning of care of a patient at risk of deteriorating. As such, do not attempt cardiopulmonary resuscitation (DNACPR) discussions have been occurring when patients are still in the emergency department. The current pandemic has increased the urgency of making sure that these patients have appropriate treatments and escalation of treatment. Initiating DNACPR discussions is often found to be difficult for medical staff, with health professionals deterred by fear of causing distress, attracting complaints and time constraints. 1 Additionally, in the UK, an evidence synthesis has found that there is variation in hospital implementation of national guidelines surrounding DNACPR decisions, 2 further complicating matters. The current UK recommendation is to discuss treatment escalation plans at the earliest and most practical opportunity. 1 The literature suggests that patients prefer having such discussions on admission to hospital or following acute deterioration 1 and that, when these discussions are part of overall treatment escalation plans, patients have improved clarity about goals of care. 2 With the complications brought about by Covid-19, however, discussions have become more ethically complex. Relatives can play a significant role during such sensitive discussions about resuscitation by supporting the patient to communicate their wishes or simply by providing a familiar face to discuss with. Furthermore, if a patient lacks capacity, the discussion about resuscitation would usually be conducted with relatives, unless such discussion had previously been refused by the patient when they had capacity. However, due to the pandemic, unless a patient cannot communicate for themselves or is approaching the end of life, the patient must attend hospital alone. Relatives have been told to remain at home. With the complications brought about by Covid-19, however, discussions have become more ethically complex. Previous work has indicated that patients prefer to have these discussions with clinicians with whom they have an established relationship, such as their regular family doctor or general practitioner. 1 Now, patients are having these discussions with doctors they do not know, with these doctors likely to be junior and potentially at a less experienced level. It should be noted that any doctor with a full license to practice in the UK (a second-year doctor or above) can have this discussion and sign a DNACPR form, while a senior responsible clinician should review this decision within 24 hours of it being signed. Training around treatment escalation and DNACPR discussions remains an unmet need for junior doctors and undergraduate medical students. Ethical approval was not deemed necessary for this work. The authors declare no conflicts of interest. https://orcid.org/0000-0003-2246-9048 CPR decision-making conversations in the UK: an integrative review Do-not-attempt-cardiopulmonary-resuscitation decisions: an evidence synthesis Preparing junior doctors for discussing DNACPR with patients -a bit of trial and error Outcomes for Graduates, Outcomes 2 -Professional skills Themes and variations: an exploratory international investigation into resuscitation decision-making How to cite this article: Davies K. Resuscitation discussions: learning from Covid-19. The Clinical Teacher